Novo CEO pressed by Senate to chop charges of obesity, diabetes medication CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would think about new talks with insurers regarding the record rates of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. Will not miss out https://dave-s-hot-chicken-nutrit07395.tblogz.com/healthcare-news-an-overview-44657329